The DOI matches its Crossref record; 76 of the 78 references it cites were found in a registry or an index.
Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice
Open accessPublished version of a preprint
Abstract
Hepatic uptake and biosynthesis of fatty acids (FA), as well as the partitioning of FA into oxidative, storage, and secretory pathways are tightly regulated processes. Dysregulation of one or more of these processes can promote excess hepatic lipid accumulation, ultimately leading to systemic metabolic dysfunction. Angiopoietin-like-4 (ANGPTL4) is a secretory protein that inhibits lipoprotein lipase (LPL) and modulates triacylglycerol (TAG) homeostasis. To understand the role of ANGPTL4 in liver lipid metabolism under normal and high-fat fed conditions, we generated hepatocyte specific Angptl4 mutant mice (Hmut). Using metabolic turnover studies, we demonstrate that hepatic Angptl4 deficiency facilitates catabolism of TAG-rich lipoprotein (TRL) remnants in the liver via increased hepatic lipase (HL) activity, which results in a significant reduction in circulating TAG and cholesterol levels. Consequently, depletion of hepatocyte Angptl4 protects against diet-induce obesity, glucose intolerance, liver steatosis, and atherogenesis. Mechanistically, we demonstrate that loss of Angptl4 in hepatocytes promotes FA uptake which results in increased FA oxidation, ROS production, and AMPK activation. Finally, we demonstrate the utility of a targeted pharmacologic therapy that specifically inhibits Angptl4 gene expression in the liver and protects against diet-induced obesity, dyslipidemia, glucose intolerance, and liver damage, which likely occurs via increased HL activity. Notably, this novel inhibition strategy does not cause any of the deleterious effects previously observed with neutralizing antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“hepatocyte-specific deletion of ANGPTL4 attenuated obesity, liver steatosis, and atherosclerosis in high-fat-diet mice [32].”
From Identifying novel drug targets for calcific aortic valve disease through Mendelian randomization (2025) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,094
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, É., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,840
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Regulation of hepatic glucose metabolism in health and disease
Petersen, M. C., Vatner, D. F., & Shulman, G. I. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.80 · Cited by 1,159
Dyslipidemia in type 2 diabetes mellitus
Mooradian, A. D. (2009) · Nature Reviews Endocrinology · doi:10.1038/ncpendmet1066 · Cited by 1,053
Flagged first, then by citations
2 of the 78 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 10.1172/JCI22422 · DOI · Paper page
Cited by
Sorted by citations
Addressing dyslipidemic risk beyond LDL-cholesterol
Tall, A. R., Thomas, D. G., Gonzalez-Cabodevilla, A. G., & Goldberg, I. J. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148559 · Cited by 150
Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism
Kersten, S. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100150 · Cited by 151
Ferroptosis Signaling and Regulators in Atherosclerosis
Wang, Y., Zhao, Y., Ye, T., Yang, L. M., Shen, Y., & Li, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.809457 · Cited by 136
Mouse models of atherosclerosis in translational research
Ilyas, I., Little, P. J., Liu, Z., Xu, Y., Kamato, D., Berk, B. C., Weng, J., & Xu, S. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.06.009 · Cited by 124
Triglyceride-rich lipoproteins and cardiovascular diseases
Xu, D., Xie, L., Cheng, C., Xue, F., & Sun, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1409653 · Cited by 73
Suppression of angiopoietin-like 4 reprograms endothelial cell metabolism and inhibits angiogenesis
Chaube, B., Citrin, K. M., Sahraei, M., Singh, A. K., de Urturi, D. S., Ding, W., Pierce, R. W., Raaisa, R., CARDONE, R. L., Kibbey, R. G., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43900-0 · Cited by 73
Self-citationDual role of ANGPTL4 in inflammation
Zuo, Y., He, Z., Chen, Y., & Dai, L. (2023) · Inflammation Research · doi:10.1007/s00011-023-01753-9 · Cited by 64
Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
Kim, T. H., Hong, D.-G., & Yang, Y. M. (2021) · Biomedicines · doi:10.3390/biomedicines9121903 · Cited by 57
Astrocytic lipid metabolism determines susceptibility to diet-induced obesity
Varela, L., Kim, J. G., Fernández‐Tussy, P., Aryal, B. K., Liu, Z. W., Fernandez-Hernando, C. F., & Horváth, T. L. (2021) · Science Advances · doi:10.1126/sciadv.abj2814 · Cited by 44
Self-citationTargeting the vasculature in cardiometabolic disease
Boutagy, N. E., Singh, A. K., & Sessa, W. C. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148556 · Cited by 45
Self-citationThe Regulation of Triacylglycerol Metabolism and Lipoprotein Lipase Activity
Wen, Y., Chen, Y., & Konrad, R. J. (2022) · Advanced Biology · doi:10.1002/adbi.202200093 · Cited by 43
Severe hypertriglyceridemia: Existing and emerging therapies
Malick, W. A., Do, R., & Rosenson, R. S. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108544 · Cited by 44
Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease
Srivastava, S. P., Zhou, H., Shenoi, R., Morris, M., Lainez, B., Goedeke, L., Rajendran, B. K., Setia, O., Aryal, B. K., Kanasaki, K., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn6068 · Cited by 41
Self-citationAltabas, V., & Biloš, L. S. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052663 · Cited by 36
Miao, X., Alidadipour, A., Saed, V., Sayyadi, F., Jadidi, Y., Davoudi, M., Amraee, F., Jadidi, N., & Afrisham, R. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02335-9 · Cited by 37
Pellegata, N. S., Berriel Diaz, M., Rohm, M., & Herzig, S. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10058-y · Cited by 33
Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target
Milani, I., Codini, M., Guarisco, G., Chinucci, M., Gaita, C., Leonetti, F., & Capoccia, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910795 · Cited by 40
Silbernagel, G., Chen, Y., Li, H., Lemen, D., Wen, Y., Zhen, Y., Rief, M., Kleber, M. E., Delgado, G., Sarzynski, M. A., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.069272 · Cited by 30
Deng, M., Kutrolli, E., Sadewasser, A., Michel, S., Joibari, M. M., Jaschinski, F., Olivecrona, G., Nilsson, S. K., & Kersten, S. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100237 · Cited by 30
Shrestha, N., Chaturvedi, P., Zhu, X., Dee, M. J., George, V., Janney, C., Egan, J. O., Liu, B., Foster, M., Marsala, L. I., et al. (2023) · Aging Cell · doi:10.1111/acel.13806 · Cited by 27
Smolka, C., Schlösser, D., Hohnloser, C., Bemtgen, X., Jänich, C., Schneider, L. A., Martin, J., Pfeifer, D., Moser, M., Hasselblatt, P., et al. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00364-6 · Cited by 27
Liu, H., Yin, H., Wang, Z., Yuan, Q., Xu, F., Chen, Y., & Li, C. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05642-1 · Cited by 27
Interorgan communication with the liver: novel mechanisms and therapeutic targets
Zhao, J., Zhang, X., Li, Y., Yu, J., Chen, Z., Niu, Y., Ran, S., Wang, S., Ye, W., Luo, Z., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1314123 · Cited by 31
Self-citationSun, J., Xie, F., Wang, J., Luo, J., Chen, T., Jiang, Q., Xi, Q., Liu, G. E., & Zhang, Y. (2024) · Microbiome · doi:10.1186/s40168-023-01743-3 · Cited by 29
Self-citationLiu, X., Zhang, Y., Han, B., Li, L., Li, Y., Ma, Y., Kang, S., Li, Q., Kong, L., Huang, K., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.181553 · Cited by 25
Zhang, X., Yuan, S., Zhang, X., Zhang, T., Meng, C., Zhuang, K., & Dang, S. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112706 · Cited by 23
Self-citationLandfors, F., Chorell, E., & Kersten, S. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100313 · Cited by 24
Golden‐Mason, L., Salomon, M. P., Matsuba, C., Wang, Y., Setiawan, V. W., Chatzi, L., & Maretti-Mira, A. C. (2025) · Environment International · doi:10.1016/j.envint.2025.109763 · Cited by 25
Chronic high-fat feeding and prolonged fasting in liver-specific ANGPTL4 knockout mice
Spitler, K. M., Shetty, S. K., Cushing, E. M., Sylvers-Davie, K. L., & Davies, B. S. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00144.2021 · Cited by 23
Bacil, G. P., Romualdo, G. R., Rodrigues, J., & Barbisan, L. F. (2023) · Food Research International · doi:10.1016/j.foodres.2023.113513 · Cited by 23
PFOS-elicited metabolic perturbation in liver and fatty acid metabolites in testis of adult mice
Lee, W. K., Lam, T. K. Y., Tang, H. C., Ho, T. C., Wan, H. T., & Wong, C. K. C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1302965 · Cited by 22
Jia, C., Li, X., Pan, J., Ma, H., Wu, D., Lü, H., Wang, W., Zhang, X., & Yi, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1135827 · Cited by 22
Self-citationAngiopoietin-like proteins and postprandial partitioning of fatty acids
DiDonna, N., Chen, Y. Q., & Konrad, R. J. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000798 · Cited by 20
Viruses and neurodegeneration: a growing concern
Shouman, S., Hesham, N., & Salem, T. Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-06025-6 · Cited by 19
Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNA
Brinton, E. A., Eckel, R. H., Gaudet, D., Ballantyne, C. M., Baker, B. F., Ginsberg, H. N., & Witztum, J. L. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119114 · Cited by 21
Impact of loss-of-function in angiopoietin-like 4 on the human phenome
Gagnon, E., Bourgault, J., Gobeil, É., Thériault, S., & Arsenault, B. J. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117558 · Cited by 17
Modder, M., Panhuis, W. I. H., Li, M., Afkir, S., Dorn, A. L., Pronk, A. C. M., Streefland, T. C. M., Lalai, R. A., Pierrou, S. E., Nilsson, S. K., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae195 · Cited by 17
Social Bonds Retain Oxytocin-Mediated Brain-Liver Axis to Retard Atherosclerosis
Ko, S., Anzai, A., Liu, X., Kinouchi, K., Yamanoi, K., Torimitsu, T., Ichihara, G., Kitakata, H., Shirakawa, K., Katsumata, Y., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.324638 · Cited by 19
ANGPTL4: A Comprehensive Review of 25 Years of Research
Ramos, P., Shi, Q., Kleberg, J., Maharjan, C. K., Zhang, W., & Kolb, R. H. (2025) · Cancers · doi:10.3390/cancers17142364 · Cited by 20
ANGPTL4: a new mode in the regulation of intravascular lipolysis
Ploug, M. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000800 · Cited by 16
Oldham, D., Wang, H., Mullen, J., Lietzke, E. E., Sprenger, K. G., Reigan, P., Eckel, R. H., & Bruce, K. D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.926631 · Cited by 14
Vahdat‐Lasemi, F., Farhoudi, L., Hosseinikhah, S. M., Santos, R. D., & Sahebkar, A. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119235 · Cited by 14
Berthou, F., Sobolewski, C., Abegg, D., Fournier, M., Maeder, C., Dolicka, D., de Sousa, M. C., Adibekian, A., & Foti, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073959 · Cited by 14
Renal lipid accumulation and aging linked to tubular cells injury via ANGPTL4
Wang, X., Chang, H.-C., Gu, X., Han, W., Mao, S., Lu, L., Jiang, S., Ding, H., Han, S., Qu, X., et al. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111932 · Cited by 12
ANGPTL4—A protein involved in glucose metabolism, lipid metabolism, and tumor development
Xu, Z., & Jiang, G. (2024) · The Journal of Gene Medicine · doi:10.1002/jgm.3740 · Cited by 12
Chu, J., Yang, Y., Zhang, K., Fu, Y., & Yuan, B. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.115125 · Cited by 12
Non-alcoholic fatty liver disease and liver secretome
Khan, M. S., Lee, C.-H., & Kim, S. G. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01419-w · Cited by 13
Brain-acting hepatokines: its impact on energy balance and metabolism
Giovanini, L., Wanionok, N. E., Perelló, M., & Cornejo, M. P. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1589110 · Cited by 15
ANGPTL4-the Link Binding Lipid Metabolism and Inflammation
Zhang, Y., Liang, J., Li, Z., Zuo, Y., & Dai, L. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673320024240829070906 · Cited by 11
Lai, Z., Wang, C., Liu, X., Sun, H., Guo, Z., Shao, J., Li, K., Chen, J., Wang, J., Lei, X., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04723-1 · Cited by 12
Identifying novel drug targets for calcific aortic valve disease through Mendelian randomization
Xu, D., Lu, J., Yang, Y., Hu, W., Chen, J., Xue, J., Yang, S., Cao, N., Hu, H., Qian, N., et al. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119110 · Cited by 10
Fucoidan, as a marine bioactive substance, has shown great potential in regulating the bone-gut axis
Zhao, Z., Sun, H., Fu, Y., Liang, X., Fan, T., Li, X., Zhu, L., Xu, L., Wang, X., Li, J., et al. (2023) · Algal Research · doi:10.1016/j.algal.2023.103323 · Cited by 10
Li, Z.-F., & Wu, N. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.911429 · Cited by 11
Siri, G., Nikrad, N., Keshavari, S., Jamshidi, S., Fayyazishishavan, E., Ardekani, A. M., Farhangi, M. A., & Jafarzadeh, F. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01279-5 · Cited by 10
RNA interference-based therapies for the control of atherosclerosis risk factors
Kettunen, S., Ruotsalainen, A., & Ylä‐Herttuala, S. (2022) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000972 · Cited by 10
Oleuropein as a Therapeutic Agent for Non-alcoholic Fatty Liver Disease During Hepatitis C
Sotoudeheian, M., Hoseini, S., Mirahmadi, S., Farahmandian, N., & Pazoki–Toroudi, H. (2023) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-023-00396-5 · Cited by 9
Zhang, Y., Zhu, Z., Sun, L., Yin, W., Liang, Y. J., Chen, H., Bi, Y., Zhai, W., Yin, Y., & Zhang, W. (2023) · Nutrients · doi:10.3390/nu15081838 · Cited by 8
Gadiraju, B., Magisetty, J., & Kondreddy, V. K. R. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137235 · Cited by 8
MiR-203 is an anti-obese microRNA by targeting apical sodium-dependent bile acid transporter
Liu, X., Cheng, F., Bai, X., Zhao, T., Zhao, L., Wang, L., Li, M., Wu, X., Chen, X., Tang, P., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104708 · Cited by 8
Characterization of sexual dimorphism in ANGPTL4 levels and function
Deng, M., & Kersten, S. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100526 · Cited by 8
Kuo, C., Wang, S., Juan, H.-C., Chen, S., Kuo, C., Kuo, H., Lin, S., & Li, H. (2024) · BioFactors · doi:10.1002/biof.2076 · Cited by 8
Liu, X., Wang, S., Liu, G., Wang, Y., Shang, S., Zou, G., Jiang, S., Wang, X., Li, Y., & Li, W. (2024) · Theranostics · doi:10.7150/thno.101498 · Cited by 7
Aydın, S., Tekinalp, S. G., Tuzcu, B., Çam, F., Sevik, M. O., Tatar, E., Kalaskar, D. M., & Çam, M. E. (2024) · Obesity Medicine · doi:10.1016/j.obmed.2024.100577 · Cited by 8
PPARβ/δ as a promising molecular drug target for liver diseases: A focused review
Meng, X., Wang, L., Du, Y.-C., Cheng, D., & Zeng, T. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102343 · Cited by 7
Differential Effects of Bariatric Surgery on Plasma Levels of ANGPTL3 and ANGPTL4.
Bini, S., D’Erasmo, L., Astiarraga, B., Minicocci, I., Palumbo, M., Pecce, V., Polito, L., Costanzo, A. D., Haeusler, R. A., Arca, M., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.08.019 · Cited by 7
ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance
Gomes, D. B. R., Sobolewski, C., Conzelmann, S., Schaer, T., Lefai, É., Alfaiate, D., Tseligka, E. D., Goossens, N., Tapparel, C., Negro, F., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-33728-5 · Cited by 7
Hypothalamic astrocytes: connecting brain and periphery in metabolic control
Thuc, O. L., Lechner, F. M., & García‐Cáceres, C. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09995-0 · Cited by 6
Single-cell transcriptomics reveals the impact of sex and age in the healthy human liver
Rahman, R. U., Epstein, E. T., Murphy, S. M., Amir-Zilberstein, L., Aubin, C., Delorey, T. M., Koene, H., Fernandes, L., Tanabe, K. K., Qadan, M., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101773 · Cited by 7
Qin, W., Ding, Y., Zhang, W., Sun, L., Weng, J., Zheng, X., & Luo, S. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100740 · Cited by 6
Gagnon, É., Gill, D., Chabot, D., Cronjé, H. T., Yuan, S., Brennan, S., Thériault, S., Burgess, S., Arsenault, B. J., & Dib, M. (2025) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.124.004933 · Cited by 8
Multilayer regulation of postprandial triglyceride metabolism in response to acute cold exposure
Zhang, Y., Zhou, S., Zhao, R., Xiong, C., Huang, Y., Zhang, M., & Wang, Y. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100751 · Cited by 5
Osteoclast-derived arachidonic acid triggers dormant lung adenocarcinoma cell activation
Liu, X., Qiu, R., Gui, P., Wei, L., Lu, Y., Deng, Y., Yang, X., Su, Y. H., Huang, Q., & Du, Y. (2025) · iScience · doi:10.1016/j.isci.2025.112167 · Cited by 5
Perera, D. J., Domenech, P., Babuadze, G. G., Naghibosadat, M., Alvarez, F., Koger-Pease, C., Labrie, L., Stuible, M., Durocher, Y., Piccirillo, C. A., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107612 · Cited by 6
Mao, G., Xu, W.-H., Wan, L., Wang, H.-P., Xu, S., Zhang, L., Li, S., Zhang, J., Lai, Z.-M., Lan, Y., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1353915 · Cited by 7
Alisol B alleviates MASLD by activating liver autophagy and fatty acid oxidation via Ces2a
Zhang, C., Chen, L., Jiang, Y., Qiu, J., Lin, Y., Ren, G. R., Xu, F., Xi, J., Yu, Z., Rong, X., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114768 · Cited by 5
Deciphering the regulatory networks of human male germline development from embryo to adulthood
Chen, J., Yang, X., Cui, M., Yao, Z., Ouyang, Z., Qu, Z., Huang, Y., Zhu, Y., Zhao, J., & Chang, G. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167918 · Cited by 4
Liu, R., Xi, Y., Duan, X., Zhao, Y., & Tian, Z. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123628 · Cited by 4
From model to man: Understanding Tregs' dual role in MASLD
Dywicki, J., Buitrago‐Molina, L. E., Baumann, A., Davalos-Misslitz, A., Hendriks, C. M., Hupa-Breier, K., Lieber, M., Schlué, J., Blüher, M., Bantel, H., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101619 · Cited by 6
Knockdown of ANGPTL4 inhibits adipogenesis of preadipocyte via autophagy
Ling, M., Qian, H., & Guo, H. (2024) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-024-00861-y · Cited by 4
Nowowiejska, J., Baran, A. M., Hermanowicz, J. M., Mikłosz, J., Kamiński, K. A., Kondraciuk, M., Dubatówka, M., Pawlak, D., & Flisiak, I. (2022) · Metabolites · doi:10.3390/metabo12090877 · Cited by 4
Jamshed, L., Jamshed, S., Frank, R., Hewitt, L. M., Thomas, P. J., & Holloway, A. C. (2024) · Toxics · doi:10.3390/toxics12090631 · Cited by 4
Gut fungi exacerbates gallstone formation by activating neutrophil extracellular traps in the liver
Lu, D., ding, H., Feng, S., Hang, F., Tian, K., Huang, Z., Shi, Y., Xue, D., Liu, L., & Meng, X. (2026) · APOPTOSIS · doi:10.1007/s10495-025-02213-x · Cited by 3
Fu, Y., Hu, P., Hu, Y., Fang, Y., Zhou, Y., Shi, Y., Yang, K., Fu, T., Li, W., Gritskevitch, E., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16309 · Cited by 2
Zhang, H., He, C., Pu, Z., Guo, L., Pan, L., Gong, H., Zhang, J., Laghari, F., Jin, S., & Zhang, R. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111872 · Cited by 2
Liu, S., Meng, M., Huang, C., He, L., Wang, P., Tang, Z., Ran, X., Gao, H., Guo, Y., He, Y., et al. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/6683126 · Cited by 2
R-spondin 2 suppresses hepatic steatosis via activation of AMPK-ACC signaling
Aithabathula, R. V., Singla, B., Kathuria, I., Pervaiz, N., Sharma, B. K., Samake, T. I., Ofosu-Boateng, M., Gebreyesus, L. H., Gyamfi, M. A., Sprague, C., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101551 · Cited by 2
Intestinal enteroendocrine cell subtype differentiation and hormone production in zebrafishPreprint
Morash, M., Kay, R. G., Soderblom, E. J., MacLean, G. H., Wen, J., Moore, P. J., Lickwar, C. R., Gribble, F. M., Reimann, F. M., Liddle, R. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.17.633579 · Cited by 2
Metabolic reprogramming by endothelial ANGPTL4 depletion protects against diabetic kidney diseasePreprint
Srivastava, S. P., Zhou, H., Shenoi, R., Morris, M., Lainez, B., Takagaki, Y., Rajendran, B. K., Setia, O., Aryal, B. K., Kanasaki, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.08.652142 · Cited by 2
Self-citationDynamic and Homeostatic Neuron–Astrocyte Interactions at GABAergic Synapses
Clarke, D., Lacaille, J., & Robitaille, R. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04554-0 · Cited by 1
Daff, K., Han, Y., Feng, Z., Upadhyay, M., Sivampeta, V., Rajasekaran, A., Sangwan, N., & Cresci, G. (2026) · Antioxidants · doi:10.3390/antiox15050537 · Cited by 1
Eccles, J. A., Johnson, T. D., & Baldwin, W. S. (2025) · Biomedicines · doi:10.3390/biomedicines13020295 · Cited by 1
Singh, A. K., Chaube, B., Citrin, K., Fowler, J. W., Lee, S., Catarino, J., Knight, J., Lowery, S. C., Shree, S., Boutagy, N., et al. (2023) · bioRxiv · doi:10.1101/2023.11.13.566870 · Cited by 1
Self-citationRegulatory mechanisms of fasting
Ruppert, P. M. M. (2020) · doi:10.18174/527117
Subramanian, P., Gargani, S., Kontoyiannis, D. L., & Chavakis, T. (2022) · Hepatology · doi:10.1002/hep.32790
Low, Z. S., Chua, D., Cheng, H. S., Tee, R., Tan, W., Ball, C., Sahib, N. B. E., Ng, S. S., Qu, J. T., Liu, Y., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.10.523354 · Cited by 1
Torun, C., Cüre, O., Cengiz, K., İlkkılıç, K., Algün, E., Donma, M. M., Tuncer, S. Ç., Altan, N., Dinçel, A. S., Kosava, F., et al. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3053
Anti-Adipogenic Effects of Complanatoside a on 3t3-L1 Adipocytes and ZabrafishPreprint
Li, S., Zhou, C., Wang, M., Dong, Y., Mao, M., Zhou, M., Liu, C., Cao, M., & Wang, Y. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4802940
Mao, G., Xu, W., Wan, L., Wang, H., Xu, S., Zhang, L., Li, S., Liu, P., Lai, Z., Lan, Y., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4426524/v1
Patent highlights December 2023–January 2024
Mucke, H. A. (2024) · Pharmaceutical Patent Analyst · doi:10.1080/20468954.2024.2390353
Yu, S., Ji, P., Du, T., Liu, Z., Yang, Y., Lv, Z., Xu, L., Jin, Q., Gong, W., Le, Y., et al. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025145
Metadata
- Authors
- Singh, A. K., Chaube, B., Zhang, X., Sun, J., Citrin, K. M., Canfrán-Duque, A., Aryal, B., Rotllan, N., Varela, L., Lee, R. G., Horvath, T. L., Price, N. L., Suárez, Y., & Fernández-Hernando, C.
- Affiliations
- Yale University (US)
- Ionis Pharmaceuticals (United States) (US)
- Corresponding author
- Suárez, Yajaira
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2021-09-01
- Volume
- 131
- Issue
- 17
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC8409581
- OpenAlex
- W3182800692
- Cited by
- 115
- References
- 78
- Citations by year
- 2026: 12 · 2025: 29 · 2024: 28 · 2023: 16 · 2022: 17 · 2021: 12
- FWCI
- 12.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R35HL135820)
- National Institute of Diabetes and Digestive and Kidney Diseases (5F32DK10348902)
- American Heart Association (16EIA27550005, 20TPA35490202, 17SDG33110002, 20TPA35490416)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- ANGPTL4, hepatocyte-specific knockout, hepatic lipid metabolism, hepatic lipase, lipoprotein lipase, diet-induced obesity, impaired glucose tolerance, hepatic steatosis, atherosclerosis, fatty acid oxidation, AMPK activation, reactive oxygen species, dyslipidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
